Great Point Partners’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.26M | Buy |
485,859
+14,895
| +3% | +$223K | 4.72% | 6 |
|
|
2025
Q1 | $5.51M | Buy |
470,964
+28,203
| +6% | +$330K | 2.92% | 15 |
|
|
2024
Q4 | $10.1M | Sell |
442,761
-561,530
| -56% | -$12.8M | 4.77% | 8 |
|
|
2024
Q3 | $42.1M | Hold |
1,004,291
| – | – | 12.4% | 1 |
|
|
2024
Q2 | $36.5M | Hold |
1,004,291
| – | – | 7% | 2 |
|
|
2024
Q1 | $51.1M | Buy |
1,004,291
+10,062
| +1% | +$512K | 7.97% | 1 |
|
|
2023
Q4 | $19.3M | Buy |
+994,229
| New | +$19.3M | 3.28% | 14 |
|
|
2020
Q3 | – | Sell |
-703
| Closed | -$233K | – | 38 |
|
|
2020
Q2 | $233K | Sell |
703
-1,314
| -65% | -$436K | 0.02% | 35 |
|
|
2020
Q1 | $459K | Buy |
+2,017
| New | +$459K | 0.05% | 32 |
|
|
2015
Q4 | – | Sell |
-5,000
| Closed | -$1.41M | – | 24 |
|
|
2015
Q3 | $1.41M | Buy |
+5,000
| New | +$1.41M | 0.56% | 27 |
|